SCHEMBL31198992

SCHEMBL31198992

O=C(OCc1ccccc1)N1CCC(CCC2OCCO2)CC1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ NPC1 O15118 2/20 0.62
▸ RAB9A P51151 2/20 0.62
▸ MEN1 O00255 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ FAAH O00519 1/20 0.57
▸ GRIN2B Q13224 10/20 0.57
▸ CYP2D6 P10635 4/20 0.56
▸ CYP2C9 P11712 4/20 0.56
▸ HTT P42858 1/20 0.54
▸ CHRM4 P08173 1/20 0.53
▸ CYP3A4 P08684 3/20 0.53
▸ PREP P48147 1/20 0.49
▸ TPSAB1 Q15661 1/20 0.47
▸ TPSD1 Q9BZJ3 1/20 0.47
▸ TPSG1 Q9NRR2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15140566 0.90 SMN1; SMN2 (0.72) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL31198766 0.89 CHRM4 (0.53) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL458148 0.84 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL21553751 0.84 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL27152787 0.84 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL6823133 0.83 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL13519706 0.83 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL1837621 0.83 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL7369976 0.83 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL4364637 0.83 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676922-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF DEGRADING ANDROGEN RECEPTORS Astrazeneca AB (SE) 2026-01-14 — — EP disclosed
WO-2024189488-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF DEGRADING ANDROGEN RECEPTORS ASTRAZENECA AB (SE) 2024-09-19 — — WO disclosed
Send feedback